LineaGen Research Corporation Revenue and Competitors
Estimated Revenue & Valuation
- LineaGen Research Corporation's estimated annual revenue is currently $3.6M per year.
- LineaGen Research Corporation's estimated revenue per employee is $135,000
- LineaGen Research Corporation's total funding is $61M.
Employee Data
- LineaGen Research Corporation has 27 Employees.
- LineaGen Research Corporation grew their employee count by -27% last year.
LineaGen Research Corporation Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $21.6M | 80 | 5% | N/A | N/A |
#2 | $219M | 649 | 7% | N/A | N/A |
#3 | $50.5M | 170 | N/A | N/A | N/A |
#4 | $52.5M | 181 | 14% | $47.5M | N/A |
#5 | $138.4M | 410 | 10% | N/A | N/A |
#6 | $17.3M | 71 | 6% | N/A | N/A |
#7 | $13188.8M | 34891 | 37% | N/A | N/A |
#8 | $7.8M | 38 | -28% | $3M | N/A |
#9 | $21.6M | 80 | N/A | N/A | N/A |
#10 | $12.9M | 53 | 20% | N/A | N/A |
What Is LineaGen Research Corporation?
LineaGen Research Corporation, formally GenData Research Corp., is a contract research and licensing organization that utilizes a powerful population genetics discovery platform to identify and validate biomarkers, coordinate clinical trials, and identify health-promoting and disease-causing genetic factors. LineaGen provides industry partners with breakthrough genetic research programs that leverage an extensive biosample repository coupled with detailed clinical data and decades of medical and genetic information from both population-based studies and studies on multigenerational families. LineaGen’s key asset is its ability to facilitate commercial access to research using the Utah Population Database; an unmatched integration of vital statistics, clinical records, and genealogical information. Currently, the Utah Population Database comprises more than 7 million linked records, including genealogical records, population records, and vital statistics that are all linked to medical information.
keywords:N/A
$61M
Total Funding
27
Number of Employees
$3.6M
Revenue (est)
-27%
Employee Growth %
N/A
Valuation
N/A
Accelerator
LineaGen Research Corporation's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Patient Service Coordinator | Reveal Email/Phone |
2 | VP Strategy & Operations | Reveal Email/Phone |
3 | Accounting Specialist | Reveal Email/Phone |
4 | Consultant | Reveal Email/Phone |
5 | Territory Manager | Reveal Email/Phone |
6 | Insurance Case Management Specialist | Reveal Email/Phone |
7 | Territory Manager | Reveal Email/Phone |
8 | Senior Territory Manager, GA, AL, IA, KS,MO | Reveal Email/Phone |
9 | Director, Pediatric Genetics | Reveal Email/Phone |
10 | Chief Medical Officer | Reveal Email/Phone |
LineaGen Research Corporation News
The Company offers OGM solutions for applications across basic, translational and clinical research. Through its Lineagen business,...
The Company offers OGM solutions for applications across basic, translational and clinical research. Through its Lineagen business,...
This analysis allows cancer researchers to gain important insights ... Through its Lineagen business, the Company also provides diagnostic...
Lineagen, Inc., a Salt Lake City, Utah-based molecular diagnostics company focused on disorders of childhood development, closed the second and final tranche of its $15.8m Series C round of financing. In 2013, it had raised the first tranche of $3.5m (read here). The final tranche of $12.17m i ...
Lineagen, Inc., a Salt Lake City, Utah-based molecular diagnostics company focused on complex, genetically linked disorders, completed a $3.5m series C round of financing. The round, which included $2.6m in equity capital and $0.9m in convertible senior subordinated notes, was led by existing i ...
Other Companies in Millcreek
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $10M | 43 | -25% | N/A |
#2 | $3.5M | 57 | 14% | N/A |
#3 | $12.5M | 62 | 11% | N/A |
#4 | $20.3M | 77 | -9% | $250.3M |
#5 | $20.8M | 99 | 10% | N/A |